As mentioned earlier, patients with pre-existing obesity may have experienced more substantial metabolic improvements, including significant weight loss and improved insulin sensitivity, which are key drivers of glucose normalization and potentially result in higher remission rates [31]. The gene discussed is INS; the disease is obesity disorder.